Example: Heart Attack

Clinical Trials Sponsored by Revalesio Corporation

Total 13 results

NCT04693715

Not yet recruiting

Safety of RNS60 in Large Vessel Occlusion Stroke Participants Undergoing Endovascular Thrombectomy

Conditions: Stroke, Ischemic
NCT02988297

Not yet recruiting

Nebulized RNS60 for the Treatment of Amyotrophic Lateral Sclerosis

Conditions: Amyotrophic Lateral Sclerosis
NCT02523794

Terminated

Study of Electro-kinetically Modified Water for the Treatment of Pain Associated With Endometriosis

Conditions: Pelvic Pain
NCT02497222

Withdrawn

Pilot Study of RNS60 in Allergen-induced Bronchoconstriction

Conditions: Asthma
NCT02490865

Completed

Systemic Bioactivity of Inhaled Nebulized RNS60

Conditions: Systemic Bioactivity of Nebulized RNS60
NCT02422121

Completed

Effect of RNS60 on the Late Phase Asthmatic Response to Allergen Challenge

Conditions: Asthma
NCT02005523

Withdrawn

Study of RNS60 on Pain and Function After Hip Labral Repair

Conditions: Hip Labral Tear
NCT01922427

Withdrawn

Study of RNS60 on Pain and Function After Knee Anterior Cruciate Ligament Surgery

Conditions: Anterior Cruciate Ligament Reconstruction
NCT01714089

Withdrawn

Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis

Conditions: Relapsing Remitting Multiple Sclerosis
NCT01511302

Completed

Study of Inhaled RNS60 in Combination With Budesonide to Treat Mild to Moderate Asthma

Conditions: Asthma
NCT01264783

Completed

Safety and Tolerability of RNS60 Given by IV to Healthy Subjects

Conditions: Myocardial Infarct
NCT01057498

Completed

Safety Study of Nebulized RNS60 to Treat Asthma.

Conditions: Asthma
NCT00823446

Completed

Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers

Conditions: Venous Stasis Ulcers